These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36894309)

  • 61. Feasibility of a hospital outpatient day procedure for medication abortion at 13-18 weeks gestation: Findings from Nepal
    Blum J; Karki C; Tamang A; Shochet T; Shrestha A; Tuladhar H; Karki A; Sharma J; Abbas DF; Dragoman M; Winikoff B
    Contraception; 2019 Dec; 100(6):451-456. PubMed ID: 31491379
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Accuracy of self-assessment of gestational duration among people seeking abortion.
    Ralph LJ; Ehrenreich K; Barar R; Biggs MA; Morris N; Blanchard K; Kapp N; Moayedi G; Perritt J; Raymond EG; White K; Grossman D
    Am J Obstet Gynecol; 2022 May; 226(5):710.e1-710.e21. PubMed ID: 34922922
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Self reported outcomes and adverse events after medical abortion through online telemedicine: population based study in the Republic of Ireland and Northern Ireland.
    Aiken ARA; Digol I; Trussell J; Gomperts R
    BMJ; 2017 May; 357():j2011. PubMed ID: 28512085
    [No Abstract]   [Full Text] [Related]  

  • 64. Efficacy and acceptability of a mifepristone-misoprostol combined regimen for early induced abortion among women in Mexico City.
    Peña M; Dzuba IG; Smith PS; Mendoza LJ; Bousiéguez M; Martínez ML; Polanco RR; Villalón AE; Winikoff B
    Int J Gynaecol Obstet; 2014 Oct; 127(1):82-5. PubMed ID: 24957534
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Exploring Canadian women's knowledge of and interest in mifepristone: results from a national qualitative study with abortion patients.
    Vogel KI; LaRoche KJ; El-Haddad J; Chaumont A; Foster AM
    Contraception; 2016 Aug; 94(2):137-42. PubMed ID: 27125893
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Clinical Outcomes and Women's Experiences before and after the Introduction of Mifepristone into Second-Trimester Medical Abortion Services in South Africa.
    Constant D; Harries J; Malaba T; Myer L; Patel M; Petro G; Grossman D
    PLoS One; 2016; 11(9):e0161843. PubMed ID: 27583448
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Acceptability and feasibility of mifepristone medical abortion in the early first trimester in Azerbaijan.
    Louie KS; Tsereteli T; Chong E; Aliyeva F; Rzayeva G; Winikoff B
    Eur J Contracept Reprod Health Care; 2014 Dec; 19(6):457-64. PubMed ID: 25047120
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The efficacy of medical abortion: a meta-analysis.
    Kahn JG; Becker BJ; MacIsaa L; Amory JK; Neuhaus J; Olkin I; Creinin MD
    Contraception; 2000 Jan; 61(1):29-40. PubMed ID: 10745067
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Multicenter trial of a simplified mifepristone medical abortion regimen.
    Shannon CS; Winikoff B; Hausknecht R; Schaff E; Blumenthal PD; Oyer D; Sankey H; Wolff J; Goldberg R
    Obstet Gynecol; 2005 Feb; 105(2):345-51. PubMed ID: 15684163
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Outcomes of suction curettage and mifepristone abortion in the United States. A prospective comparison study.
    Jensen JT; Astley SJ; Morgan E; Nichols MD
    Contraception; 1999 Mar; 59(3):153-9. PubMed ID: 10382077
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prevalence, attitudes and knowledge of misoprostol for self-induction of abortion in women presenting for abortion at Midwestern reproductive health clinics.
    Kerestes C; Sheets K; Stockdale CK; Hardy-Fairbanks AJ
    Sex Reprod Health Matters; 2019 Dec; 27(1):1571311. PubMed ID: 31533561
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A non-inferiority study of outpatient mifepristone-misoprostol medical abortion at 64-70 days and 71-77 days of gestation.
    Dzuba IG; Chong E; Hannum C; Lichtenberg ES; Lugo Hernández EM; Ngoc NTN; Patel A; Rzayeva G; Sanhueza Smith P; Tsertsvadze G; Winikoff B
    Contraception; 2020 May; 101(5):302-308. PubMed ID: 32014520
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Comparison of Outcomes before and after Ohio's Law Mandating Use of the FDA-Approved Protocol for Medication Abortion: A Retrospective Cohort Study.
    Upadhyay UD; Johns NE; Combellick SL; Kohn JE; Keder LM; Roberts SC
    PLoS Med; 2016 Aug; 13(8):e1002110. PubMed ID: 27575488
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Provision of medical abortion by midlevel healthcare providers in Kyrgyzstan: testing an intervention to expand safe abortion services to underserved rural and periurban areas.
    Johnson BR; Maksutova E; Boobekova A; Davletova A; Kazakbaeva C; Kondrateva Y; Landoulsi S; Lazdane G; Monolbaev K; Seuc Jo AH
    Contraception; 2018 Feb; 97(2):160-166. PubMed ID: 29133110
    [TBL] [Abstract][Full Text] [Related]  

  • 75. TelAbortion: evaluation of a direct to patient telemedicine abortion service in the United States.
    Raymond E; Chong E; Winikoff B; Platais I; Mary M; Lotarevich T; Castillo PW; Kaneshiro B; Tschann M; Fontanilla T; Baldwin M; Schnyer A; Coplon L; Mathieu N; Bednarek P; Keady M; Priegue E
    Contraception; 2019 Sep; 100(3):173-177. PubMed ID: 31170384
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Mifepristone and misoprostol compared with misoprostol alone for second-trimester abortion: a randomized controlled trial.
    Ngoc NTN; Shochet T; Raghavan S; Blum J; Nga NTB; Minh NTH; Phan VQ; Winikoff B
    Obstet Gynecol; 2011 Sep; 118(3):601-608. PubMed ID: 21860289
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Expulsion at home for early medical abortion: A systematic review with meta-analyses.
    Schmidt-Hansen M; Pandey A; Lohr PA; Nevill M; Taylor P; Hasler E; Cameron S
    Acta Obstet Gynecol Scand; 2021 Apr; 100(4):727-735. PubMed ID: 33063314
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Can women in less-developed countries use a simplified medical abortion regimen?
    Elul B; Hajri S; Ngoc NN; Ellertson C; Slama CB; Pearlman E; Winikoff B
    Lancet; 2001 May; 357(9266):1402-5. PubMed ID: 11356438
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prospective open-label non-inferiority randomised controlled trial comparing letrozole and mifepristone pretreatment in medical management of first trimester missed miscarriage: study protocol.
    Du L; Li RHW; Gemzell-Danielsson K; Du YH; Zhang L; Diao WY; Ho PC
    BMJ Open; 2022 Jan; 12(1):e052192. PubMed ID: 35105623
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Early pregnancy termination with mifepristone and misoprostol in Norway.
    Bjørge L; Johnsen SL; Midbøe G; Augestad G; Økland I; Helland H; Stray-Pedersen S; Iversen OE
    Acta Obstet Gynecol Scand; 2001 Nov; 80(11):1056-61. PubMed ID: 11703208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.